Virtual US FDA Advisory Committees May Have One Silver Lining: Available Experts

This article provides insights on what the pharmaceutical and medical device industry can expect now that FDA Advisory Committee meetings are being held virtually in response to the COVID-19 pandemic.

Now that FDA has announced it will be conducting virtual Advisory Committee meetings as COVID-19 rages on, it’s clear pharmaceutical and medical device companies have many obstacles to overcome – including communications and technical challenges.  Jim DiBiasi sat down with Kate Rawson from Pink Sheet to talk about what to expect, the challenges in running these high-stakes meetings virtually, and what 3D Communications is doing to prepare pharma clients for different scenarios.

Click here to read more: https://pink.pharmaintelligence.informa.com/PS142255/Virtual-US-FDA-Advisory-Committees-May-Have-One-Silver-Lining-Available-Experts

This article was originally featured in Pink Sheet on May 22, 2020.